Institutional Conflict of Interest Management and Monitoring Plan: OmniNano Pharmaceuticals LLCOption & License Agreement • October 31st, 2024
Contract Type FiledOctober 31st, 2024The University of Texas MD Anderson (MD Anderson) and OmniNano Pharmaceuticals LLC (OmniNano) are parties to an Option & License Agreement (Agreement). Under the Agreement, MD Anderson grants a royalty-bearing, exclusive license to certain patent rights pertaining to novel polymeric drug delivery for systemic treatment of pancreatic ductal adenocarcinoma.